Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 AUD | 0.00% | +4.30% | +18.21% |
02-26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
02-25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.21% | 391M | |
+20.40% | 43.95B | |
+22.22% | 22.49B | |
+14.63% | 14.71B | |
+11.01% | 13.77B | |
+42.56% | 12.3B | |
-8.70% | 7.03B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.75% | 5.48B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma Group Secures $3.4 Million Manufacturing Grant